초기 독성 시험 시장 규모 - 방법별, 최종사용자별 - 지역별 전망, 경쟁 전략, 부문별 예측(-2033년)

Early Toxicity Testing Market Introduction and Overview

According to SPER market research, 'Early Toxicity Testing Market Size- By Technique, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Early Toxicity Testing Market is predicted to reach USD 2.58 billion by 2033 with a CAGR of 7.41%.

Early toxicity assessment of novel compounds is used to develop medications and increase the therapeutic potential of existing molecules. It is carried out in pre-clinical phases on numerous biological systems to explore the species, organs, and dose-specific harmful effects of a substance. It can be carried out in a variety of ways, including in vivo on animals, in vitro in laboratories with tests, and in silico on a computer. It is also used to research accidental exposures to a chemical.

Recognizing the urgent need for COVID-19 therapies and vaccinations, regulatory agencies accelerated review processes and extended regulatory flexibility. This may have altered the regulatory landscape for early toxicity testing, with shorter approval timelines and a stronger emphasis on real-time data sharing and collaboration. The epidemic prompted collaboration and collaborations among academia, industry, and government to boost COVID-19 research efforts.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Technique, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific

Global Early Toxicity Testing Market Segmentation:

By Technique: Based on the Technique, Global Early Toxicity Testing Market is segmented as; In vivo, In silico, In vitro.

By End User: Based on the End User, Global Early Toxicity Testing Market is segmented as; Pharmaceuticals industry, Cosmetics industry, Chemicals industry, Food industry, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Early Toxicity Testing Market.

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Early Toxicity Testing Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Early Toxicity Testing Market

7. Global Early Toxicity Testing Market, By Technique (USD Million) 2020-2033

7.1. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2020-2026

• 7.2. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2027-2033
• 7.3. In vivo
• 7.4. In silico
• 7.5. In vitro

8. Global Early Toxicity Testing Market, By End User (USD Million) 2020-2033

• 8.1. Global Early Toxicity Testing Market Size, Share and Forecast, By End User, 2020-2026
• 8.2. Global Early Toxicity Testing Market Size,Share and Forecast, By End User, 2027-2033
• 8.3. Pharmaceuticals industry
• 8.4. Cosmetics industry
• 8.5. Chemicals industry
• 8.6. Food industry
• 8.7. Others

9. Global Early Toxicity Testing Market Forecast, 2020-2033 (USD Million)

• 9.1. Global Early Toxicity Testing Market Size and Market Share

10. Global Early Toxicity Testing Market, By Region, 2020-2033 (USD Million)

• 10.1. Global Early Toxicity Testing Market Size and Market Share By Region (2020-2026)
• 10.2. Global Early Toxicity Testing Market Size and Market Share By Region (2027-2033)
• 10.3. Asia-Pacific
  • 10.3.1. Australia
  • 10.3.2. China
  • 10.3.3. India
  • 10.3.4. Japan
  • 10.3.5. South Korea
  • 10.3.6. Rest of Asia-Pacific
• 10.4. Europe
  • 10.4.1. France
  • 10.4.2. Germany
  • 10.4.3. Italy
  • 10.4.4. Spain
  • 10.4.5. United Kingdom
  • 10.4.6. Rest of Europe
• 10.5. Middle East and Africa
  • 10.5.1. Kingdom of Saudi Arabia
  • 10.5.2. United Arab Emirates
  • 10.5.3. Qatar
  • 10.5.4. South Africa
  • 10.5.5. Egypt
  • 10.5.6. Morocco
  • 10.5.7. Nigeria
  • 10.5.8. Rest of Middle East & Africa
• 10.6. North America
  • 10.6.1. Canada
  • 10.6.2. Mexico
  • 10.6.3. United States
• 10.7. Latin America
  • 10.7.1. Argentina
  • 10.7.2. Brazil
  • 10.7.3. Rest of Latin America

11. Company Profile

• 11.1. Agilent Technologies
  • 11.1.1. Company details
  • 11.1.2. Financial outlook
  • 11.1.3. Product summary
  • 11.1.4. Recent developments
• 11.2. Accelrys
  • 11.2.1. Company details
  • 11.2.2. Financial outlook
  • 11.2.3. Product summary
  • 11.2.4. Recent developments
• 11.3. BD bioscience
  • 11.3.1. Company details
  • 11.3.2. Financial outlook
  • 11.3.3. Product summary
  • 11.3.4. Recent developments
• 11.4. Bio-rad
  • 11.4.1. Company details
  • 11.4.2. Financial outlook
  • 11.4.3. Product summary
  • 11.4.4. Recent developments
• 11.5. Bioanalytical Systems
  • 11.5.1. Company details
  • 11.5.2. Financial outlook
  • 11.5.3. Product summary
  • 11.5.4. Recent developments
• 11.6. Charles River Laboratories
  • 11.6.1. Company details
  • 11.6.2. Financial outlook
  • 11.6.3. Product summary
  • 11.6.4. Recent developments
• 11.7. Evotec AG
  • 11.7.1. Company details
  • 11.7.2. Financial outlook
  • 11.7.3. Product summary
  • 11.7.4. Recent developments
• 11.8. Enzo Biochem Inc
  • 11.8.1. Company details
  • 11.8.2. Financial outlook
  • 11.8.3. Product summary
  • 11.8.4. Recent developments
• 11.9. Eurofins Scientific
  • 11.9.1. Company details
  • 11.9.2. Financial outlook
  • 11.9.3. Product summary
  • 11.9.4. Recent developments
• 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links